Group 1 - The eighth China International Import Expo (CIIE) was held in Shanghai from November 5 to 10, showcasing the transformation of the German children's nutrition brand inne from product output to industry collaboration [1] - Inne launched two new products, including a liquid calcium supplement specifically designed for pregnant and breastfeeding women, reflecting a shift in industry focus from marketing-driven to efficacy validation [1] - The increasing attention to "clinical evidence" among professional audiences indicates a trend towards scientific validation in the industry, aligning with inne's approach of building a scientific verification system in collaboration with top-tier hospitals in China [1] Group 2 - The release of the "Children's Calcium Quality Standards" establishes technical specifications based on calcium sources and dosage forms, addressing the rapid growth and demand in the children's nutrition market in China [2] - Statistics show that the number of users purchasing children's calcium products on the JD platform increased by 30% year-on-year, with a repurchase rate rising to 45%, highlighting the market's growth potential [2] - The standard provides parents with clear, actionable guidelines and establishes a scientific evaluation system for the industry, helping to alleviate consumer "choice anxiety" caused by product homogeneity and concept marketing [2]

Core Insights - The 8th China International Import Expo will be held in Shanghai from November 5 to 10, showcasing the German high-end adult dietary nutrition brand Mom's Garden, which will present its two sub-brands, "Mom's Garden百草园" and "Mom's Garden任我行" [1] - Mom's Garden views the Chinese market as a crucial part of its global strategy and a core driver of its growth, aiming to leverage the expo's "spillover effect" to introduce more German research-based dietary solutions tailored to Chinese consumer needs [1][2] - The expo serves as a bridge for global companies to share opportunities in China and deepen local cooperation, with Mom's Garden focusing on integrating global research advantages with local health demands [1] Product Focus - Mom's Garden will highlight its scientific nutritional achievements in bone health and gut health, showcasing products like the popular "任我行液体钙" from its bone health sub-brand and various products from its gut health sub-brand [2] - The expo is positioned not just as a product showcase but as a connector of value and trust, with Mom's Garden planning activities such as a "clinical evidence" press conference and the establishment of the 任我行 Bone Health Research Institute to build a trust loop from professionals to consumers [2] - Mom's Garden aims to extend its value chain in the Chinese market by transforming showcased innovations into products for Chinese households and planning local R&D investments, aligning with the "Healthy China" strategy [2]

Core Insights - The article highlights the increasing importance of clinical research and scientific data in the selection of children's nutritional products by parents [1][2] - Inne has made significant advancements in clinical projects through its Institute of Nutrition and Health, collaborating with various research institutions to validate the efficacy of its selected ingredients [1] - Recent research on Inne's DHA supplementation has shown improvements in memory in mice, with results published in the authoritative journal eFood, indicating the scientific credibility of the findings [1][2] Group 1 - Inne's recent academic conference focused on the clinical evidence of calcium supplementation, showcasing its commitment to scientific innovation in the children's nutrition sector [2] - The company has previously published research on its patented Kidtal ingredient, which enhances bone density and strength, in the well-known journal Nutrients [2] - Inne aims to transition the industry from experience-driven practices to evidence-based approaches, emphasizing the importance of rigorous clinical research in children's nutrition [2] Group 2 - The challenges of conducting clinical research in children's nutrition, including long research cycles and individual variability, are acknowledged as critical for industry advancement and consumer trust [2] - Inne plans to continue building a product matrix based on evidence-based medicine, translating cutting-edge research into practical health support for consumers [2] - The company aspires to define the "gold standard" in children's nutrition through clinical evidence, providing better nutritional choices for parents and children [2]

Core Viewpoint - The article emphasizes the urgent need for a scientific standard in calcium supplementation for children, highlighting the widespread issue of insufficient calcium intake and the confusion among parents regarding various products available in the market [1][2]. Group 1: Industry Developments - Inne has initiated a milestone academic conference titled "Clinical Evidence: A New Era of Scientific Calcium Supplementation," collaborating with various experts and industry leaders to discuss the significance of clinical evidence in driving industry standards [1][2]. - The conference has garnered significant attention from authoritative media outlets, marking a shift towards a more regulated and professional landscape in the children's nutrition industry, thereby establishing Inne's leadership position [2]. Group 2: Scientific Advancements - Inne is recognized as the first brand in the industry to systematically promote clinical validation, aiming to redefine industry standards through rigorous scientific research and evidence [2][8]. - The company has introduced innovative products, such as a liquid calcium supplement that addresses absorption issues, and has established a scientific age-based system for calcium supplementation [6][8]. Group 3: Expert Insights - Dr. Yu Wen, a pediatrician, emphasized the importance of clinical evidence as the gold standard for selecting calcium supplements, advocating for the necessity of clinical research to validate product effectiveness and safety [6][8]. - The latest research on Inne's patented ingredient, Kidtal, has been published in a top nutrition journal, demonstrating its unique advantages in promoting children's growth and development [8]. Group 4: Institutional Initiatives - Inne has established the Institute of Nutrition and Health to address the long-standing issue of unverifiable product claims in the children's nutrition sector, aiming to provide scientific validation for product safety and efficacy [9]. - The institute's establishment marks a new phase in Inne's commitment to scientific innovation and industry responsibility, encouraging other brands to prioritize clinical research [9]. Group 5: Consumer Perspectives - A prominent consumer representative highlighted the confusion parents face due to the overwhelming number of products lacking real clinical data, stressing that clinically validated products can alleviate parenting anxiety [10]. - The presence of clinical evidence provides parents with confidence in their choices, moving beyond mere marketing claims [10]. Group 6: Global Positioning - Inne adheres to German pharmaceutical standards and has received various certifications, ensuring high-quality production and safety for its products [11]. - The company has established partnerships with major pharmacies in Germany and has gained popularity in the Chinese market, leading sales on major e-commerce platforms [11]. Group 7: Future Directions - The successful conclusion of the academic conference sets a new standard for scientific calcium selection based on clinical evidence, positioning Inne as a leader in the children's nutrition field [12]. - Inne aims to continue leveraging evidence-based medicine to develop professional nutrition products that withstand clinical efficacy tests, driving transformative upgrades in the industry [12].

Core Insights - The 24th CBME International Baby, Maternity & Children Industry Expo in Shanghai showcased over 4,500 brands and attracted more than 100,000 professional visitors, marking a record scale for the event [1] - Inne, a German children's nutrition brand, highlighted its commitment to scientific nutrition through a groundbreaking academic conference focused on clinical evidence for calcium supplementation, shifting the industry towards evidence-based marketing [1][5] Group 1: Event Highlights - Inne's exhibition featured an immersive booth designed around the theme "Pinnacle Nutrition, Leading Growth," with a model of Mount Everest symbolizing the brand's pursuit of excellence [3] - The conference gathered industry experts and scholars, including notable figures from top hospitals, to discuss the importance of clinical evidence in advancing children's nutrition [5][6] Group 2: Product Innovations - Inne introduced upgraded products, including a liquid calcium supplement for children under 6 and a proprietary ingredient, Kidtal, aimed at enhancing bone growth during puberty, with research published in the journal "Nutrients" [4][6] - The company also presented clinically validated eye care products for children, which have shown effectiveness in alleviating visual fatigue and protecting against blue light damage [4][6] Group 3: Consumer Engagement - The exhibition attracted significant consumer interest, with interactive installations that allowed families to engage with the brand and learn about scientific nutrition [7] - Parents shared positive experiences with Inne products, emphasizing the brand's transparency in clinical research and its impact on children's health and growth [8] Group 4: Industry Impact - Inne's participation at CBME set a new benchmark for the industry by emphasizing the role of clinical evidence in driving high-quality development in children's nutrition [9] - The company plans to continue focusing on consumer needs and deepening clinical research to provide effective and transparent nutritional solutions for children's health [9]

Core Insights - The 24th CBME International Baby, Child & Maternity Industry Expo in Shanghai showcased over 4,500 brands and attracted more than 100,000 professional visitors, marking a new record in scale [1] - Inne's participation highlighted its commitment to clinical evidence in children's nutrition, launching a new standard for calcium supplementation based on scientific validation [4][5] - The brand's immersive exhibition theme "Peak Nutrition, Leading Growth" was visually represented by a model of Mount Everest, symbolizing its pursuit of excellence in research and product development [2] Company Highlights - Inne introduced upgraded products, including a liquid calcium supplement for children under 6 and a specialized calcium product for adolescents, both backed by clinical research published in the journal "Nutrients" [3][4] - The company hosted a significant academic conference on clinical evidence in calcium supplementation, featuring renowned experts and showcasing its global clinical validation system [4][5] - Inne's interactive exhibition attracted consumer engagement, with activities designed to promote scientific nutrition concepts among families [6][8] Industry Impact - The conference emphasized the importance of clinical evidence in driving high-quality development within the children's nutrition industry, setting a benchmark for future advancements [5][8] - Inne's approach to transparency in clinical research has resonated with consumers, enhancing trust and confidence in its products [7] - The brand aims to continue leading the industry by focusing on scientific research and addressing consumer needs, ensuring the health and growth of children globally [8]

Core Viewpoint - The article emphasizes the importance of "clinical validation" as a critical standard for evaluating children's health products, particularly calcium supplements, in the context of evolving scientific parenting concepts [1][6]. Group 1: Industry Trends - The children's nutrition industry is transitioning from "experience-driven" to "evidence-based" approaches, with a focus on clinical validation to establish new standards for calcium supplementation [3][14]. - Over 50% of calcium supplements in the market are still basic forms like calcium carbonate and lactate, with only 15% having undergone clinical trials, indicating a significant gap in scientific validation [4][6]. Group 2: Company Initiatives - Inne, a German-origin children's nutrition brand, has launched a comprehensive clinical validation system and hosted an academic conference titled "Clinical Validation: A Revolutionary Approach to Scientific Calcium Supplementation" [1][3]. - The company has established global research centers in Germany, China, Australia, and the USA, focusing on high-absorption, preservative-free nutritional products [4][11]. Group 3: Clinical Research and Findings - Clinical studies conducted in collaboration with reputable institutions have shown that Inne's proprietary ingredient, Kidtal, significantly promotes growth and bone health in children aged 2-12 [7][8]. - Research published in the international journal "Nutrients" has validated the effectiveness of Kidtal, enhancing its credibility in the scientific community [8][9]. Group 4: Future Directions - Inne plans to continue its commitment to scientific innovation and deepen clinical research collaborations to provide safer, more effective nutritional solutions for children's health [15].